GENEVA, July 9 -- SHANGHAI ZHUANMA BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/147288) for “SYSTEMATICALLY OPTIMIZED ACCAS12N GENE EDITING SYSTEM AND USE THEREOF”. With publication no. WO/2026/145550, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/85
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....